Welcure Drugs and Pharmaceuticals Ltd. (WDPL), established on June 4, 1992, specializes in manufacturing bulk drugs, drug intermediates, and pharmaceutical formulations. With a diverse product portfolio including ampicillin, trimethoprim, and over a hundred varieties of tablets, capsules, and syrups, WDPL is expanding its offerings to include amoxycillin, cloxacillin, and ibuprofen. The company has diversified into pediatric and veterinary drugs and ventured into ointments and liquid syrups. Notably, it holds ISO 9002 certification and collaborates with international firms, such as a Russian company for Stevioside and a New Jersey-based entity for joint ventures.
WDPL's marketing strategy shifted from wholesale distribution to doorstep sales, enhancing its market reach. The company also engages in manufacturing water processing equipment and real estate development, creating spaces for modern professionals. Its subsidiary, A K Laboratories, is a key player in producing 6-APA, an intermediate for semi-synthetic penicillin, strengthening WDPL's position in the pharmaceutical sector.
